Cyrix Healthcare acquires Blue Star E&E MedTech
Analysis based on 7 articles · First reported Sep 04, 2026 · Last updated Sep 07, 2026
The acquisition is expected to strengthen Cyrix Healthcare's position in the medical imaging services market, potentially increasing its revenue and market share. For Blue Star Limited, the sale of its subsidiary's medtech business for Rs 40 crore provides a modest cash inflow and allows it to focus on its core air conditioning business.
Cyrix Healthcare, a portfolio company of Somerset Indus Capital Partners Fund III, acquired the MedTech Solutions business of Blue Star Engineering & Electronics Ltd (Blue Star E&E), effective September 1, 2026. The acquisition, valued at Rs 40 crore ($4.2 million) on a slump-sale basis, strengthens Cyrix's medical imaging capabilities, particularly in CT and MRI systems, and expands its total MedTech management platform across India, West Asia, and Africa. The deal integrates Blue Star E&E's expertise across more than 250 CT and MRI installations, enhancing Cyrix's AURUM refurbished equipment business. All existing customers of Blue Star E&E MedTech Solutions will continue to be supported by the same teams. Cyrix Healthcare employs over 1,200 biomedical engineers and manages more than 650,000 medical devices across 25,000 healthcare facilities. The acquisition is part of Cyrix's growth strategy to build a comprehensive medtech ecosystem through organic growth and acquisitions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard